Schedule: Monday - Saturday - 0:00 - 0:00, Sunday - 0:00 - 0:00
Ongoing Studies
Phase III open labelled randomized controlled study to evaluate the optimal dose of all-trans retinoic acid in the treatment of acute promyelocytic leukemia - HCC APL22 DOSA Study
CTRI Registration No: CTRI/2023/09/057990
A phase III randomized study to compare a risk-stratified and response-adapted strategy to ABVD regimen in adolescents and adults with advanced-stage Hodgkin lymphoma
CTRI Registration No: CTRI/2020/12/030132
A Phase III RCT comparing AVD+ low dose nivolumab versus ABVD using a risk-adapted strategy in newly diagnosed advanced stage classical Hodgkin lymphoma. LoNAH (Low dose nivolumab in advanced stage Hodgkin lymphoma)
COVID-19 with Hematological Cancers Registry of India (CHCRI)
Induction Related Mortality Score in Acute Myeloid Leukemia: Prospective Validation Study
CTRI Registration No: CTRI/2020/07/026450
Upcoming Studies
A multicentre Phase III randomized control trial to test the efficacy of targeted agents during induction and a response-adapted consolidation in adolescent and young adult patients with de-novo ALL
